Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,220 | -8,230 | -849 | -44 | -44 |
| Depreciation Amortization | 110 | 90 | N/A | N/A | N/A |
| Other Working Capital | -1,340 | 490 | N/A | N/A | N/A |
| Other Operating Activity | 50 | 330 | 0 | 0 | 0 |
| Operating Cash Flow | $-6,400 | $-7,320 | $-849 | $-44 | $-44 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -60 | N/A | N/A | N/A |
| Other Investing Activity | 700 | 470 | 0 | 0 | 0 |
| Investing Cash Flow | $550 | $410 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 3,071 | 7,730 | 849 | 44 | 44 |
| Financing Cash Flow | $3,070 | $7,730 | $849 | $44 | $44 |
| Beginning Cash Position | 2,980 | 2,150 | N/A | N/A | N/A |
| End Cash Position | 200 | 2,980 | N/A | N/A | N/A |
| Net Cash Flow | $-2,770 | $820 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,400 | -7,320 | -849 | -44 | -44 |
| Free Cash Flow | -6,400 | -7,320 | -849 | -44 | -44 |